Perspective Therapeutics, Inc. - COMMON STOCK (CATX)

Historical Holders from Q2 2024 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
CATX on NYSE
Shares outstanding
73,943,049
Price per share
$2.75
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
42,524,179
Total reported value
$145,860,657
% of total 13F portfolios
0%
Share change
+430,096
Value change
+$1,461,867
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
103
Price from insider filings
$2.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avidity Partners Management LP 4.2% $5,284,305 2,841,024 Avidity Partners Management LP 31 Dec 2024
FMR LLC 0.4% -98% $824,113 -$15,183,078 312,164 -95% FMR LLC 28 Nov 2025
JANUS HENDERSON GROUP PLC 0% $33,181 17,839 JANUS HENDERSON GROUP PLC 31 Dec 2024
As of 30 Sep 2025, Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 103 institutional shareholders filing 13F forms. They hold 42,524,179 shares. of 73,943,049 outstanding shares (58%) .

Top 25 institutional shareholders own 53% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FMR LLC 14% 10,010,865 -9.8% 0% $34,337,267
BlackRock, Inc. 5.9% 4,366,577 +1.7% 0% $14,977,359
VANGUARD GROUP INC 4.6% 3,437,865 +5% 0% $11,791,877
Avidity Partners Management LP 4% 2,994,033 +61% 2.3% $10,269,533
MORGAN STANLEY 3.7% 2,760,861 +70% 0% $9,469,754
MILLENNIUM MANAGEMENT LLC 3.5% 2,561,112 -1.3% 0.01% $8,784,614
Nicholson Wealth Management Group, LLC 2.2% 1,618,293 +0.25% 3.3% $5,550,745
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,432,487 +3.6% 0% $4,914,402
Nuveen, LLC 1.8% 1,308,642 -43% 0% $4,488,642
STATE STREET CORP 1.5% 1,104,704 +1.5% 0% $3,789,135
Hills Bank & Trust Co 1.3% 979,200 -0.51% 0.2% $3,358,656
BANK OF AMERICA CORP /DE/ 1.1% 785,823 +140% 0% $2,695,372
UBS Group AG 0.87% 641,143 +72% 0% $2,199,121
Walleye Capital LLC 0.74% 546,033 +191% 0.02% $1,872,893
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.72% 535,790 -0.31% 0% $1,837,760
TWO SIGMA INVESTMENTS, LP 0.7% 519,668 -14% 0% $1,782,461
SPHERA FUNDS MANAGEMENT LTD. 0.69% 510,343 +64% 0.42% $1,750,476
NORTHERN TRUST CORP 0.64% 470,960 -1.7% 0% $1,615,393
Rock Springs Capital Management LP 0.6% 444,383 0% 0.09% $1,524,234
JPMORGAN CHASE & CO 0.59% 436,357 -42% 0% $1,496,705
TWO SIGMA ADVISERS, LP 0.55% 405,630 -18% 0% $1,391,311
WealthPlan Investment Management, LLC 0.55% 404,071 +0.75% 0.09% $1,385,964
Patient Square Capital LP 0.47% 349,323 0.32% $1,198,178
JANE STREET GROUP, LLC 0.45% 329,673 0% $1,130,778
Affinity Asset Advisors, LLC 0.41% 300,000 -71% 0.1% $1,029,000

Institutional Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 19,256 $52,954 -$45,463 $2.75 2
2025 Q3 42,524,179 $145,860,657 +$1,461,867 $3.43 103
2025 Q2 42,232,957 $145,284,060 +$679,388 $3.44 95
2025 Q1 44,107,303 $93,948,689 -$10,507,950 $2.13 109
2024 Q4 47,101,348 $150,249,113 -$74,925,842 $3.19 132
2024 Q3 49,033,906 $653,981,856 +$116,531,831 $13.35 126
2024 Q2 38,539,321 $384,225,008 +$383,938,572 $9.97 102